Ignite Creation Date:
2025-12-24 @ 9:09 PM
Ignite Modification Date:
2026-06-25 @ 1:35 AM
Study NCT ID:
NCT04091204
Status:
UNKNOWN
Last Update Posted:
2023-03-24
First Post:
2019-09-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Olaparib in Patients With Recurrent Ovarian Cancer Wild Type for Germline and Somatic BRCA 1 and 2 Genes: The MITO 31 Translational Study
Sponsor:
National Cancer Institute, Naples
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
MITO 31
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None